Operating Company Healthcare

Apotex

Toronto, Ontario, Canada

Global pharmaceutical company headquartered in Toronto, Canada. Portfolio includes more than 550 generic, biosimilar and innovative medicines and more than 225 natural health products, serving people across the Americas via pharmaceutical licensing and product acquisitions.

Focus Areas
Generic medicines, Biosimilars, Branded pharmaceuticals
Website
apotex.com

Tracked deals

3

3 tracked deals across 2024-2026.

Recent pace

1

1 tracked deal announced in the last 12 months.

Deal mix

Buyout

2 buyout · 1 divestiture

Apotex Acquisition Volume by Year

Last 3 years

Acquisition volume by year Annual acquisition counts for the last 3 years for Apotex. 1 2024 1 2025 ~2 est. 1 2026
Actual Full-year estimate

Supporting Data

Recent Transactions

  • Apotex Acquires Cumberland Pharmaceuticals’ U.S. Branded Portfolio for $100M
    April 23, 2026
    Buyer
    Apotex, Apotex Health Corp., an affiliate of Apotex
    Target
    Cumberland Pharmaceuticals Inc. (U.S. branded pharmaceutical portfolio/line of branded pharmaceuticals)
    Seller
    Cumberland Pharmaceuticals Inc.
    Industry
    Pharmaceuticals
    Location
    Tennessee, United States
    Type
    Divestiture

    Apotex entered into an agreement with an affiliate of Apotex to acquire Cumberland Pharmaceuticals’ line of branded pharmaceuticals for $100 million in cash. The deal is designed to integrate Cumberland’s FDA-approved U.S. brands into Apotex’s specialty and hospital-focused business, while Cumberland retains its pipeline product candidates (including ifetroban) and majority ownership of Cumberland Emerging Technologies.

  • Apotex Acquires CanPrev
    February 3, 2025
    Buyer
    Apotex Inc.
    Target
    CanPrev
    Seller
    Franco Salituro, Tanya Salituro
    Industry
    Consumer Products
    Location
    Ontario, Canada
    Type
    Buyout

    Apotex Inc. has acquired CanPrev, a Canadian natural health company known for its CanPrev, Cyto-Matrix, and Orange Naturals brands. The deal brings Apotex into the Canadian health and wellness consumer market, expanding its channels into health food stores, naturopathic/professional channels, grocery retail and strengthening its consumer health product portfolio.

  • Apotex Acquires Searchlight Pharma
    April 2, 2024
    Buyer
    Apotex Inc.
    Target
    Searchlight Pharma Inc.
    Industry
    Pharmaceuticals
    Location
    Quebec, Canada
    Type
    Buyout

    Apotex Inc. has completed the acquisition of Montreal-based Searchlight Pharma Inc., integrating Searchlight as Apotex's Specialty Pharma Division to expand its branded and specialty pharmaceutical capabilities. The deal adds Searchlight's portfolio of more than 60 products across women's health, dermatology, allergy, pain management and hospital specialty markets, and strengthens Apotex's commercial footprint in Quebec and across the Americas.

Related Acquisition Pages

Pharmaceuticals Buyers & Acquisitions 2 tracked deals by Apotex. Consumer Products Buyers & Acquisitions 1 tracked deal by Apotex. Acquisitions in Tennessee 1 tracked deal by Apotex.

Selling a company? Get in front of buyers like Apotex

Turn tracked acquisition activity into an outreach-ready buyer list.

Find buyers like these →